Pilot Project Program
试点项目计划
基本信息
- 批准号:10628882
- 负责人:
- 金额:$ 41.5万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-04-01 至 2028-02-29
- 项目状态:未结题
- 来源:
- 关键词:AddressApplications GrantsCancer BiologyCancer CenterCollaborationsCritiquesDataData CollectionDiagnosticEligibility DeterminationEnsureExtramural ActivitiesFee-for-Service PlansFeesFoundationsFundingFunding AgencyGoalsGrantInstitutionInvestmentsJournalsMalignant neoplasm of pancreasMidwestern United StatesMissionNorth DakotaPeer ReviewPhasePilot ProjectsProcessPublicationsResearchResearch PersonnelSourceSystemTherapeuticTimeUnited States National Institutes of HealthUniversitiesWorkanticancer researchbaseinnovationprogramsstemsuccessvoucher
项目摘要
Abstract
A major component of Phase III CoBRE funding for the Center for Cancer Biology Research (CCBR) is funding
of a Pilot Grant Program. The Pilot Grant Program's mission is to promote innovative and impactful cancer
research in the Midwest. The CCBR's on-going Pilot Grant Program has been tremendously successful in
funding projects that ultimately contributed to publications in peer-reviewed journals as well as grant funding
from the National Institutes of Health as well as foundations. A great majority of Pilot Grant awardees utilize the
CCBR's Scientific Cores. As these investigators obtain larger funding sources, they continue to rely on the
CCBR's Cores for generating needed data. Thus, the ultimate success of the Pilot Grant Program is a clear
investment in the CCBR and its Scientific Cores. Included within the Pilot Grant Program will be a Voucher
Program which will provide funds for Core usage. We expect this program to be highly successful as the CCBR's
Scientific Cores are well known in the region for their quality work and quick turnaround time. The Voucher
program will provide the ability for investigators to utilize the Scientific Cores, providing a means for obtaining
data that will ultimately contribute to publications and extramural funding. In these ways, the Pilot Grant program
will significantly contribute to the self-sustainability of the Scientific Cores. Moreover, many Pilot Grants stem
from collaborations between CCBR PIs and investigators from other centers or institutions. Thus, the Pilot Grant
Program will continue to expand the CCBR itself, as well.
摘要
癌症生物学研究中心(CCBR)第三阶段CoBRE资助的一个主要组成部分是资助
一个试点补助计划。试点赠款计划的使命是促进创新和有影响力的癌症
在中西部进行研究。CCBR正在进行的试点赠款计划取得了巨大成功,
资助最终在同行评审期刊上发表论文的项目,以及赠款资金
来自国家卫生研究院和基金会。绝大多数试点补助金获得者利用
CCBR的科学核心随着这些调查人员获得更大的资金来源,他们继续依赖
用于生成所需数据的CCBR核心。因此,试点赠款计划的最终成功是一个明确的
投资CCBR及其科学核心。试点补助金计划中将包括一张代金券
将为核心使用提供资金的计划。我们希望这个项目能够取得巨大成功,因为CCBR的
Scientific Cores以其高质量的工作和快速的周转时间在该地区闻名。凭证
该计划将为研究人员提供利用科学核心的能力,提供获得
这些数据最终将有助于出版物和校外资金。在这些方面,试点赠款计划
这将大大有助于科学核心的自我维持。此外,许多试点赠款
CCBR PI与其他中心或机构的研究者之间的合作。因此,试点补助金
该计划还将继续扩大CCBR本身。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
W KEITH MISKIMINS其他文献
W KEITH MISKIMINS的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('W KEITH MISKIMINS', 18)}}的其他基金
(PQA1)Molecular mechanisms by which the diabetic drug metformin kills cancer cell
(PQA1)糖尿病药物二甲双胍杀死癌细胞的分子机制
- 批准号:
8712424 - 财政年份:2013
- 资助金额:
$ 41.5万 - 项目类别:
(PQA1)Molecular mechanisms by which the diabetic drug metformin kills cancer cell
(PQA1)糖尿病药物二甲双胍杀死癌细胞的分子机制
- 批准号:
8858397 - 财政年份:2013
- 资助金额:
$ 41.5万 - 项目类别:
(PQA1)Molecular mechanisms by which the diabetic drug metformin kills cancer cell
(PQA1)糖尿病药物二甲双胍杀死癌细胞的分子机制
- 批准号:
8590394 - 财政年份:2013
- 资助金额:
$ 41.5万 - 项目类别:
(PQA1)Molecular mechanisms by which the diabetic drug metformin kills cancer cell
(PQA1)糖尿病药物二甲双胍杀死癌细胞的分子机制
- 批准号:
9063480 - 财政年份:2013
- 资助金额:
$ 41.5万 - 项目类别: